The effect of cigarette smoke on fibroblast-mediated gel contraction is dependent on cell density

Cigarette smoke exposure has been associated with a variety of diseases, including emphysema. The current study evaluated the interaction of cell density and cigarette smoke extract (CSE) on fibroblast contraction of collagen gels. Protein levels of transforming growth factor (TGF)-beta1, fibronectin, PGE(2), and TGF-beta1 mRNA were quantified. Although both 5 and 10% CSE inhibited contraction by low-density fibroblasts (1 x 10(5) cell/ml), only 5% CSE augmented contraction in higher-density cultures (3-5 x 10(5) cells/ml). CSE also inhibited fibronectin and TGF-beta1 production in low-density cultures but stimulated fibronectin production in high-density cultures. Active TGF-beta1 was readily detectable only in higher-density cultures and was markedly augmented by 5% CSE. In contrast, although TGF-beta1 mRNA expression was inhibited in high-density cultures by 10% CSE, expression was increased in the presence of 5% CSE. These results suggest that CSE-induced inhibition of low-density fibroblast contraction is due to inhibition of fibronectin production, whereas CSE's stimulatory effect on high-density cells is the result of increased release of TGF-beta1. These effects may help explain the varied pathologies associated with exposure to cigarette smoke.

[1]  S. Rennard,et al.  Phenol sulfotransferase expression in the airways: enzymological and immunohistochemical demonstration , 1993, Cell and Tissue Research.

[2]  S. Rennard,et al.  Localization of the human fibronectin (FN) gene on chromosome 8 by a specific enzyme immunoassay , 1981, Biochemical Genetics.

[3]  D. A. Schwartz,et al.  Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. , 2002, American journal of respiratory and critical care medicine.

[4]  D. Sheppard,et al.  The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1 , 2002, The Journal of cell biology.

[5]  D. Rifkin,et al.  The integrin αVβ6 binds and activates latent TGFβ3 , 2002 .

[6]  D. Rifkin,et al.  The integrin alphaVbeta6 binds and activates latent TGFbeta3. , 2002, FEBS letters.

[7]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[8]  D. Romberger,et al.  Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. , 2001, American journal of respiratory cell and molecular biology.

[9]  N. Wahab,et al.  Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. , 2001, Journal of the American Society of Nephrology : JASN.

[10]  B. Boyan,et al.  The First Stage of Transforming Growth Factor β1 Activation is Release of the Large Latent Complex from the Extracellular Matrix of Growth Plate Chondrocytes by Matrix Vesicle Stromelysin-1 (MMP-3) , 2001, Calcified Tissue International.

[11]  H. Ehrlich,et al.  Differences in the mechanism for high‐ versus moderate‐density fibroblast‐populated collagen lattice contraction , 2000, Journal of cellular physiology.

[12]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[13]  S. Masur,et al.  TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts. , 2000, Investigative ophthalmology & visual science.

[14]  J. Simons,et al.  Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. , 1999, Biochemical and biophysical research communications.

[15]  T. Sacchi,et al.  Elevation of serum cardiac troponin I in noncardiac and cardiac diseases other than acute coronary syndromes. , 1999, The American journal of emergency medicine.

[16]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[17]  R. Baumann,et al.  Pediatric sedation with analgesia. , 1999, The American journal of emergency medicine.

[18]  D. Romberger,et al.  Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[19]  T. T. Dinh,et al.  Myofibroblasts differentiate from fibroblasts when plated at low density. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Enright.  Smoking, Lung Function, and Atherosclerosis in the 5,000 Elderly Participants of the Cardiovascular Health Study. , 1994, American Journal of Geriatric Cardiology.

[21]  M. Reed,et al.  TGF‐β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors , 1994 .

[22]  D. Romberger,et al.  Spontaneous production of transforming growth factor-beta 2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro. , 1992, The Journal of clinical investigation.

[23]  C. Cross,et al.  Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. , 1992, The Biochemical journal.

[24]  D. Hartmann,et al.  Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. , 1991, The Journal of investigative dermatology.

[25]  M. Becker‐André,et al.  Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). , 1989, Nucleic acids research.

[26]  G Löfroth,et al.  Environmental tobacco smoke: overview of chemical composition and genotoxic components. , 1989, Mutation research.

[27]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.

[28]  K. Nakajima,et al.  Quantitative evaluation of the factors affecting the process of fibroblast-mediated collagen gel contraction by separating the process into three phases. , 1988, Collagen and related research.

[29]  T. Petty.  Risk factors in the development of chronic obstructive pulmonary disease. , 1983, Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting.

[30]  J. Crapo,et al.  Cell number and cell characteristics of the normal human lung. , 1982, The American review of respiratory disease.

[31]  E Bell,et al.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Carp,et al.  Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. , 1978, The American review of respiratory disease.

[33]  Jonathan Bard,et al.  COLLAGEN SUBSTRATA FOR STUDIES ON CELL BEHAVIOR , 1972, The Journal of cell biology.